2013
DOI: 10.1016/j.gastrohep.2013.06.005
|View full text |Cite
|
Sign up to set email alerts
|

Esteatohepatitis alcohólica y no alcohólica: ¿quiénes son los pacientes y qué podemos hacer por ellos?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(2 citation statements)
references
References 64 publications
0
2
0
Order By: Relevance
“…The explanation for a smaller nuclear area observed in the alcohol groups could be that the direct damage to cellular DNA is among the dangers of alcohol consumption [27]. Moderate physical activity can help reduce the hepatic oxidative stress through modulation of reactive oxygen species, increase the synthesis of antioxidant enzymes, up-regulation of protective systems against gene mutation and thermal shock, and increase growth 0.331 SC = sedentary control (no alcohol), EC = exercise control (no alcohol), EA = exercise alcohol, SA = sedentary alcohol.…”
Section: Morphometry Of Hepatocyte Nucleusmentioning
confidence: 98%
“…The explanation for a smaller nuclear area observed in the alcohol groups could be that the direct damage to cellular DNA is among the dangers of alcohol consumption [27]. Moderate physical activity can help reduce the hepatic oxidative stress through modulation of reactive oxygen species, increase the synthesis of antioxidant enzymes, up-regulation of protective systems against gene mutation and thermal shock, and increase growth 0.331 SC = sedentary control (no alcohol), EC = exercise control (no alcohol), EA = exercise alcohol, SA = sedentary alcohol.…”
Section: Morphometry Of Hepatocyte Nucleusmentioning
confidence: 98%
“…Alcohol consumption is an additive factor that potentially interacts synergistically with those metabolic risk factors commonly present in MASLD (i.e., obesity, diabetes mellitus, hypertension). 20 21 If we assume that this holds true for all MASLD patients, then we must accept that an important bias is present in the available evidence regarding the natural history of MASLD as well as in therapeutic trials that do not account accurately for alcohol consumption as a variable. Thus, every effort to avoid this bias must be made in prospective studies involving subjects with steatotic liver disease.…”
Section: Alcohol Consumption In Patients With Steatotic Liver Diseasementioning
confidence: 99%